The nuclear receptor Rev-erbα regulates adipose tissue-specific FGF21 signaling

Journal of Biological Chemistry

Volumn 291, Issue 20, 2016, Pages 10867-10875

  Jager, Jennifer ^a   Wang, Fenfen ^a   Fang, Bin ^a   Lim, Hee Woong ^a   Peed, Lindsey C ^a   Steger, David J ^a   Won, Kyoung Jae ^a   Kharitonenkov, Alexei ^b   Adams, Andrew C ^c   Lazar, Mitchell A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b INDIANA UNIVERSITY   (United States)

^c ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING SITES; CYTOLOGY; MAMMALS; TRANSCRIPTION;

ADIPOSE TISSUE; LIPID METABOLISMS; NUCLEAR RECEPTORS; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR; TARGET GENES; TRANSCRIPTIONAL REPRESSORS; WHITE ADIPOSE TISSUES;

TISSUE;

FIBROBLAST GROWTH FACTOR 21; KLOTHO PROTEIN; NUCLEAR RECEPTOR NR1D1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN KLB; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; FIBROBLAST GROWTH FACTOR; KLB PROTEIN, MOUSE; MEMBRANE PROTEIN; NR1D1 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING SITE; DOWN REGULATION; FEMALE; GENE LOCUS; GENE TARGETING; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; WHITE ADIPOSE TISSUE; ADIPOCYTE; ADIPOSE TISSUE; ANIMAL; CYTOLOGY; GENETICS; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY;

ADIPOCYTES; ADIPOSE TISSUE; ANIMALS; FEMALE; FIBROBLAST GROWTH FACTORS; MALE; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP D, MEMBER 1; PPAR GAMMA; SIGNAL TRANSDUCTION;

EID: 84969204029     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M116.719120     Document Type: Article

References (63)

1. Qatanani, M., and Lazar, M. A. (2007) Mechanisms of obesity-associated insulin resistance: many choices on the menu. Genes Dev. 21, 1443-1455
2. Anghel, S. I., and Wahli, W. (2007) Fat poetry: a kingdom for PPAR γ. Cell Res. 17, 486-511
3. Guilherme, A., Virbasius, J. V., Puri, V., and Czech, M. P. (2008) Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat. Rev. Mol. Cell Biol. 9, 367-377
4. Mathieu, P., Lemieux, I., and Després, J. P. (2010) Obesity, inflammation, and cardiovascular risk. Clin. Pharmacol. Ther. 87, 407-416
5. Ouchi, N., Parker, J. L., Lugus, J. J., and Walsh, K. (2011) Adipokines in inflammation and metabolic disease. Nat. Rev. Immunol. 11, 85-97
6. Gronemeyer, H., Gustafsson, J. A., and Laudet, V. (2004) Principles for modulation of the nuclear receptor superfamily. Nat. Rev. Drug. Discov. 3, 950-964
7. Mangelsdorf, D. J., Thummel, C., Beato, M., Herrlich, P., Schütz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P., and Evans, R. M. (1995) The nuclear receptor superfamily: the second decade. Cell 83, 835-839
8. Yang, X., Lamia, K. A., and Evans, R. M. (2007) Nuclear receptors, metabolism, and the circadian clock. Cold Spring Harbor Symp. Quant. Biol. 72, 387-394
9. Harding, H. P., and Lazar, M. A. (1995) The monomer-binding orphan receptor Rev-Erb represses transcription as a dimer on a novel direct repeat. Mol. Cell. Biol. 15, 4791-4802
10. Ishizuka, T., and Lazar, M. A. (2003) The N-CoR/histone deacetylase 3 complex is required for repression by thyroid hormone receptor. Mol. Cell. Biol. 23, 5122-5131
11. Zamir, I., Harding, H. P., Atkins, G. B., Hörlein, A., Glass, C. K., Rosenfeld, M. G., and Lazar, M. A. (1996) A nuclear hormone receptor corepressor mediates transcriptional silencing by receptors with distinct repression domains. Mol. Cell. Biol. 16, 5458-5465
12. Preitner, N., Damiola, F., Lopez-Molina, L., Zakany, J., Duboule, D., Albrecht, U., and Schibler, U. (2002) The orphan nuclear receptor REV-ERBα controls circadian transcription within the positive limb of the mammalian circadian oscillator. Cell 110, 251-260
13. Bugge, A., Feng, D., Everett, L. J., Briggs, E. R., Mullican, S. E., Wang, F., Jager, J., and Lazar, M. A. (2012) Rev-erbα and Rev-erbβ coordinately protect the circadian clock and normal metabolic function. Genes Dev. 26, 657-667
14. Duez, H., and Staels, B. (2010) Nuclear receptors linking circadian rhythms and cardiometabolic control. Arterioscler. Thromb. Vasc. Biol. 30, 1529-1534
15. Le Martelot, G., Claudel, T., Gatfield, D., Schaad, O., Kornmann, B., Lo Sasso, G., Moschetta, A., and Schibler, U. (2009) REV-ERBα participates in circadian SREBP signaling and bile acid homeostasis. PLoS Biol. 7, e1000181
16. Gibbs, J. E., Blaikley, J., Beesley, S., Matthews, L., Simpson, K. D., Boyce, S. H., Farrow, S. N., Else, K. J., Singh, D., Ray, D. W., and Loudon, A. S. (2012) The nuclear receptor REV-ERBα mediates circadian regulation of innate immunity through selective regulation of inflammatory cytokines. Proc. Natl. Acad. Sci. U.S.A. 109, 582-587
17. Woldt, E., Sebti, Y., Solt, L. A., Duhem, C., Lancel, S., Eeckhoute, J., Hesselink, M. K., Paquet, C., Delhaye, S., Shin, Y., Kamenecka, T. M., Schaart, G., Lefebvre, P., Nevière, R., Burris, T. P., Schrauwen, P., Staels, B., and Duez, H. (2013) Rev-erb-α modulates skeletal muscle oxidative capacity by regulating mitochondrial biogenesis and autophagy. Nat. Med. 19, 1039-1046
18. Gerhart-Hines, Z., Feng, D., Emmett, M. J., Everett, L. J., Loro, E., Briggs, E. R., Bugge, A., Hou, C., Ferrara, C., Seale, P., Pryma, D. A., Khurana, T. S., and Lazar, M. A. (2013) The nuclear receptor Rev-erbα controls circadian thermogenic plasticity. Nature 503, 410-413
19. Jager, J., O'Brien, W. T., Manlove, J., Krizman, E. N., Fang, B., Gerhart-Hines, Z., Robinson, M. B., Klein, P. S., and Lazar, M. A. (2014) Behavioral changes and dopaminergic dysregulation in mice lacking the nuclear receptor Rev-erbα. Mol. Endocrinol. 28, 490-498
20. Potthoff, M. J., Kliewer, S. A., and Mangelsdorf, D. J. (2012) Endocrine fibroblast growth factors 15/19 and 21: from feast to famine. Genes Dev. 26, 312-324
21. Kharitonenkov, A., and Adams, A. C. (2014) Inventing new medicines: the FGF21 story. Mol. Metab. 3, 221-229
22. Kharitonenkov, A., Shiyanova, T. L., Koester, A., Ford, A. M., Micanovic, R., Galbreath, E. J., Sandusky, G. E., Hammond, L. J., Moyers, J. S., Owens, R. A., Gromada, J., Brozinick, J. T., Hawkins, E. D., Wroblewski, V. J., Li, D. S., Mehrbod, F., Jaskunas, S. R., and Shanafelt, A. B. (2005) FGF-21 as a novel metabolic regulator. J. Clin. Invest. 115, 1627-1635
23. Coskun, T., Bina, H. A., Schneider, M. A., Dunbar, J. D., Hu, C. C., Chen, Y., Moller, D. E., and Kharitonenkov, A. (2008) Fibroblast growth factor 21 corrects obesity in mice. Endocrinology 149, 6018-6027
24. Kharitonenkov, A., Wroblewski, V. J., Koester, A., Chen, Y. F., Clutinger, C. K., Tigno, X. T., Hansen, B. C., Shanafelt, A. B., and Etgen, G. J. (2007) The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21. Endocrinology 148, 774-781
25. Wente, W., Efanov, A. M., Brenner, M., Kharitonenkov, A., Köster, A., Sandusky, G. E., Sewing, S., Treinies, I., Zitzer, H., and Gromada, J. (2006) Fibroblast growth factor-21 improves pancreatic β-cell function and survival by activation of extracellular signal-regulated kinase 1/2 and Akt signaling pathways. Diabetes 55, 2470-2478
26. Berglund, E. D., Li, C. Y., Bina, H. A., Lynes, S. E., Michael, M. D., Shanafelt, A. B., Kharitonenkov, A., and Wasserman, D. H. (2009) Fibroblast growth factor 21 controls glycemia via regulation of hepatic glucose flux and insulin sensitivity. Endocrinology 150, 4084-4093
27. Fisher, F. M., Kleiner, S., Douris, N., Fox, E. C., Mepani, R. J., Verdeguer, F., Wu, J., Kharitonenkov, A., Flier, J. S., Maratos-Flier, E., and Spiegelman, B. M. (2012) FGF21 regulates PGC-1alpha and browning of white adipose tissues in adaptive thermogenesis. Genes Dev. 26, 271-281
28. Kharitonenkov, A., Dunbar, J. D., Bina, H. A., Bright, S., Moyers, J. S., Zhang, C., Ding, L., Micanovic, R., Mehrbod, S. F., Knierman, M. D., Hale, J. E., Coskun, T., and Shanafelt, A. B. (2008) FGF-21/FGF-21 receptor interaction and activation is determined by βKlotho. J. Cell. Physiol. 215, 1-7
29. Ogawa, Y., Kurosu, H., Yamamoto, M., Nandi, A., Rosenblatt, K. P., Goetz, R., Eliseenkova, A. V., Mohammadi, M., and Kuro-o, M. (2007) βKlotho is required for metabolic activity of fibroblast growth factor 21. Proc. Natl. Acad. Sci. U.S.A. 104, 7432-7437
30. Suzuki, M., Uehara, Y., Motomura-Matsuzaka, K., Oki, J., Koyama, Y., Kimura, M., Asada, M., Komi-Kuramochi, A., Oka, S., and Imamura, T. (2008) βKlotho is required for fibroblast growth factor (FGF) 21 signaling through FGF receptor (FGFR) 1c and FGFR3c. Mol. Endocrinol. 22, 1006-1014
31. Fon Tacer, K., Bookout, A. L., Ding, X., Kurosu, H., John, G. B., Wang, L., Goetz, R., Mohammadi, M., Kuro-o, M., Mangelsdorf, D. J., and Kliewer, S. A. (2010) Research resource: comprehensive expression atlas of the fibroblast growth factor system in adult mouse. Mol. Endocrinol. 24, 2050-2064
32. Ding, X., Boney-Montoya, J., Owen, B. M., Bookout, A. L., Coate, K. C., Mangelsdorf, D. J., and Kliewer, S. A. (2012) βKlotho is required for fibroblast growth factor 21 effects on growth and metabolism. Cell Metab. 16, 387-393
33. Adams, A. C., Yang, C., Coskun, T., Cheng, C. C., Gimeno, R. E., Luo, Y., and Kharitonenkov, A. (2012) The breadth of FGF21's metabolic actions are governed by FGFR1 in adipose tissue. Mol. Metab. 2, 31-37
34. Wu, A. L., Kolumam, G., Stawicki, S., Chen, Y., Li, J., Zavala-Solorio, J., Phamluong, K., Feng, B., Li, L., Marsters, S., Kates, L., van Bruggen, N., Leabman, M., Wong, A., West, D., Stern, H., Luis, E., Kim, H. S., Yansura, D., Peterson, A. S., Filvaroff, E., Wu, Y., and Sonoda, J. (2011) Amelioration of type 2 diabetes by antibody-mediated activation of fibroblast growth factor receptor 1. Sci. Transl. Med. 3, 113ra126
35. Schupp, M., Cristancho, A. G., Lefterova, M. I., Hanniman, E. A., Briggs, E. R., Steger, D. J., Qatanani, M., Curtin, J. C., Schug, J., Ochsner, S. A., McKenna, N. J., and Lazar, M. A. (2009) Re-expression of GATA2 cooperates with peroxisome proliferator-activated receptor-γ depletion to revert the adipocyte phenotype. J. Biol. Chem. 284, 9458-9464
36. Langmead, B., Trapnell, C., Pop, M., and Salzberg, S. L. (2009) Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 10, R25
37. Heinz, S., Benner, C., Spann, N., Bertolino, E., Lin, Y. C., Laslo, P., Cheng, J. X., Murre, C., Singh, H., and Glass, C. K. (2010) Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 38, 576-589
38. Liu, T., Ortiz, J. A., Taing, L., Meyer, C. A., Lee, B., Zhang, Y., Shin, H., Wong, S. S., Ma, J., Lei, Y., Pape, U. J., Poidinger, M., Chen, Y., Yeung, K., Brown, M., Turpaz, Y., and Liu, X. S. (2011) Cistrome: an integrative platform for transcriptional regulation studies. Genome Biol. 12, R83
39. Feng, D., Liu, T., Sun, Z., Bugge, A., Mullican, S. E., Alenghat, T., Liu, X. S., and Lazar, M. A. (2011) A circadian rhythm orchestrated by histone deacetylase 3 controls hepatic lipid metabolism. Science 331, 1315-1319
40. Schmidt, S. F., Jørgensen, M., Chen, Y., Nielsen, R., Sandelin, A., and Mandrup, S. (2011) Cross species comparison of C/EBPα and PPARβ profiles in mouse and human adipocytes reveals interdependent retention of binding sites. BMC Genomics 12, 152
41. Soccio, R. E., Chen, E. R., Rajapurkar, S. R., Safabakhsh, P., Marinis, J. M., Dispirito, J. R., Emmett, M. J., Briggs, E. R., Fang, B., Everett, L. J., Lim, H. W., Won, K. J., Steger, D. J., Wu, Y., Civelek, M., Voight, B. F., and Lazar, M. A. (2015) Genetic variation determines PPARγ function and anti-diabetic drug response in vivo. Cell 162, 33-44
42. Lee, J. M., Wagner, M., Xiao, R., Kim, K. H., Feng, D., Lazar, M. A., and Moore, D. D. (2014) Nutrient-sensing nuclear receptors coordinate autophagy. Nature 516, 112-115
43. Harms, M. J., Lim, H. W., Ho, Y., Shapira, S. N., Ishibashi, J., Rajakumari, S., Steger, D. J., Lazar, M. A., Won, K. J., and Seale, P. (2015) PRDM16 binds MED1 and controls chromatin architecture to determine a brown fat transcriptional program. Genes Dev. 29, 298-307
44. Fang, B., Everett, L. J., Jager, J., Briggs, E., Armour, S. M., Feng, D., Roy, A., Gerhart-Hines, Z., Sun, Z., and Lazar, M. A. (2014) Circadian enhancers coordinate multiple phases of rhythmic gene transcription in vivo. Cell 159, 1140-1152
45. Robinson, J. T., Thorvaldsdóttir, H., Winckler, W., Guttman, M., Lander, E. S., Getz, G., and Mesirov, J. P. (2011) Integrative genomics viewer. Nat. Biotechnol. 29, 24-26
46. Step, S. E., Lim, H. W., Marinis, J. M., Prokesch, A., Steger, D. J., You, S. H., Won, K. J., and Lazar, M. A. (2014) Anti-diabetic rosiglitazone remodels the adipocyte transcriptome by redistributing transcription to PPARγ-driven enhancers. Genes Dev. 28, 1018-1028
47. Adams, A. C., Cheng, C. C., Coskun, T., and Kharitonenkov, A. (2012) FGF21 requires βklotho to act in vivo. PLoS ONE 7, e49977
48. Zhang, Y., Fang, B., Emmett, M. J., Damle, M., Sun, Z., Feng, D., Armour, S. M., Remsberg, J. R., Jager, J., Soccio, R. E., Steger, D. J., and Lazar, M. A. (2015) Gene regulation: discrete functions of nuclear receptor Rev-erbα couple metabolism to the clock. Science 348, 1488-1492
49. Core, L. J., Waterfall, J. J., and Lis, J. T. (2008) Nascent RNA sequencing reveals widespread pausing and divergent initiation at human promoters. Science 322, 1845-1848
50. Hah, N., Murakami, S., Nagari, A., Danko, C. G., and Kraus, W. L. (2013) Enhancer transcripts mark active estrogen receptor binding sites. Genome Res. 23, 1210-1223
51. Kim, T. K., Hemberg, M., Gray, J. M., Costa, A. M., Bear, D. M., Wu, J., Harmin, D. A., Laptewicz, M., Barbara-Haley, K., Kuersten, S., Markenscoff-Papadimitriou, E., Kuhl, D., Bito, H., Worley, P. F., Kreiman, G., and Greenberg, M. E. (2010) Widespread transcription at neuronal activityregulated enhancers. Nature 465, 182-187
52. Creyghton, M. P., Cheng, A. W., Welstead, G. G., Kooistra, T., Carey, B. W., Steine, E. J., Hanna, J., Lodato, M. A., Frampton, G. M., Sharp, P. A., Boyer, L. A., Young, R. A., and Jaenisch, R. (2010) Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc. Natl. Acad. Sci. U.S.A. 107, 21931-21936
53. Chawla, A., Schwarz, E. J., Dimaculangan, D. D., and Lazar, M. A. (1994) Peroxisome proliferator-activated receptor (PPAR) γ: adipose-predominant expression and induction early in adipocyte differentiation. Endocrinology 135, 798-800
54. Tontonoz, P., Hu, E., Graves, R. A., Budavari, A. I., and Spiegelman, B. M. (1994) mPPAR γ 2: tissue-specific regulator of an adipocyte enhancer. Genes Dev. 8, 1224-1234
55. Tontonoz, P., Hu, E., and Spiegelman, B. M. (1994) Stimulation of adipogenesis in fibroblasts by PPAR γ 2, a lipid-activated transcription factor. Cell 79, 1147-1156
56. Delezie, J., Dumont, S., Dardente, H., Oudart, H., Gréchez-Cassiau, A., Klosen, P., Teboul, M., Delaunay, F., Pévet, P., and Challet, E. (2012) The nuclear receptor REV-ERBα is required for the daily balance of carbohydrate and lipid metabolism. FASEB J. 26, 3321-3335
57. Lam, M. T., Cho, H., Lesch, H. P., Gosselin, D., Heinz, S., Tanaka-Oishi, Y., Benner, C., Kaikkonen, M. U., Kim, A. S., Kosaka, M., Lee, C. Y., Watt, A., Grossman, T. R., Rosenfeld, M. G., Evans, R. M., and Glass, C. K. (2013) Rev-Erbs repress macrophage gene expression by inhibiting enhancerdirected transcription. Nature 498, 511-515
58. Adams, A. C., Coskun, T., Cheng, C. C., O'Farrell, L. S., Dubois, S. L., and Kharitonenkov, A. (2013) Fibroblast growth factor 21 is not required for the antidiabetic actions of the thiazoladinediones. Mol. Metab. 2, 205-214
59. Moyers, J. S., Shiyanova, T. L., Mehrbod, F., Dunbar, J. D., Noblitt, T. W., Otto, K. A., Reifel-Miller, A., and Kharitonenkov, A. (2007) Molecular determinants of FGF-21 activity-synergy and cross-talk with PPARβ signaling. J. Cell. Physiol. 210, 1-6
60. Tong, X., Muchnik, M., Chen, Z., Patel, M., Wu, N., Joshi, S., Rui, L., Lazar, M. A., and Yin, L. (2010) Transcriptional repressor E4-binding protein 4 (E4BP4) regulates metabolic hormone fibroblast growth factor 21 (FGF21) during circadian cycles and feeding. J. Biol. Chem. 285, 36401-36409
61. Wang, Y., Solt, L. A., and Burris, T. P. (2010) Regulation of FGF21 expression and secretion by retinoic acid receptor-related orphan receptor α. J. Biol. Chem. 285, 15668-15673
62. Estall, J. L., Ruas, J. L., Choi, C. S., Laznik, D., Badman, M., Maratos-Flier, E., Shulman, G. I., and Spiegelman, B. M. (2009) PGC-1α negatively regulates hepatic FGF21 expression by modulating the heme/Rev-Erbα axis. Proc. Natl. Acad. Sci. U.S.A. 106, 22510-22515
63. Véniant, M. M., Hale, C., Helmering, J., Chen, M. M., Stanislaus, S., Busby, J., Vonderfecht, S., Xu, J., and Lloyd, D. J. (2012) FGF21 promotes metabolic homeostasis via white adipose and leptin in mice. PLoS ONE 7, e40164